Serum prostate-specific antigen and digital rectal examination for early detection of prostate cancer in a national community-based program

Urology

Volumn 47, Issue 6, 1996, Pages 863-869

  Crawford, E David ^b   DeAntoni, Edward P ^a   Etzioni, Ruth ^b   Schaefer, Virginia C ^b   Olson, Robert M ^b   Ross, Colleen A ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; EARLY DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; UNITED STATES;

EID: 0029971101     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(96)00061-1     Document Type: Article

References (21)

1. Cancer Facts and Figures - 1995. Atlanta, Ga, American Cancer Society, 1995.
2. Parker SL, Tong T, Bolden S, and Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 46: 5-28, 1996.
3. Ohori M, Wheeler TM, Kattan MW, Goto Y, and Scardino PT: Prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 154: 1818-1824, 1995.
4. Gerber GS, and Chodak GW: Routine screening for cancer of the prostate (review). J Natl Cancer Inst 83: 329-335, 1991.
5. Catalona WJ, Richie JP, Ahmann FR, Hudson MA, Scardino PT, Flanigan RC, deKernion JB, Ratliff TL, Kavoussi LR, Dalkin BL, et al: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J Urol 151: 1283-1290, 1994.
6. Catalona WJ, Smith DS, Ratliff TL, and Basler JW: Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. JAMA 270: 948-954, 1993.
7. Cooner WH, Mosley BR, Rutherford CL Jr, Beard JH, Pond HS, Terry WJ, Igel TC, and Kidd DD: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143: 1146-1152, 1990.
8. Catalona WJ, Smith DS, Ratliff TL, Dodds KM, Coplen DE, Yuan JJ, Petros JA, and Andriole GL: Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 334: 1156-1161, 1991.
9. Epstein JI, Walsh PC, Carmichael M, and Brendler CB: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer. JAMA 271: 368-374, 1994.
10. DeAntoni EP, and Crawford ED: Prostate cancer awareness week: education, service and research in a community setting. Cancer 75 (suppl): 1874-1879, 1995.
11. DeAntoni EP, Crawford ED, Stone NN, Blum DS, Berger ER, Eisenberger MA, Gambert SR, and Staggers F: Prostate cancer awareness week, 1992: a summary of key findings. Clin Invest Med 16: 448-457, 1994.
12. Office of Technology Assessment. Costs and Effectiveness of Prostate Cancer Screening in Elderly Men. Washington, DC, Office of Technology Assessment, 1995.
13. Jacobsen SJ, Lilja H, Klee GG, Wright GL Jr, Pettersson K, and Oesterling JE: Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen. Urology 44: 512-518, 1994.
14. Jacobsen SJ, Klee GG, Lilja H, Wright GL Jr, and Oesterling JE: Stability of serum prostate-specific antigen determination across laboratory, assay, and storage time. Urology 45: 447-453, 1995.
15. Lee F, Littrup PJ, Torp-Pedersen ST, Mettlin C, McHugh TA, Gray JM, Kumasaka GH, and McLeary RD: Prostate cancer: comparison of transrectal US and digital rectal examination for screening. Radiology 168: 389-394, 1988.
16. Brawer MK, Chetner MP, Beatie J, Buchner DM, Vessella RL, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen. J Urol 147: 841-845, 1992.
17. Brawer MK, Beatie J, Wender MH, Vessella RL, Preston SD, and Lange PH: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J Urol 150: 106-109, 1993.
18. Labrie F, Dupont A, Suburu R, Cusan L, Tremblay M, Gomex JL, and Emond J: Serum prostate specific antigen as pre-screening test for prostate cancer. J Urol 147: 846-851, 1992.
19. Prorok PC, Connor RJ, and Baker SG: Statistical considerations in cancer screening programs. Urol Clin North Am 17: 699-708, 1990.
20. Lubke WL, Optenberg SA, and Thompson IM: Analysis of the first-year cost of a prostate cancer screening and treatment program in the United States. J Natl Cancer Inst 86: 1790-1792, 1994.
21. Smith DS, and Catalona WJ: Interexaminer variability of digital rectal examination in detecting prostate cancer. Urology 45: 70-74, 1995.